Colon cancer screening: Which non-invasive filter tests?

Digestive Diseases

Volumn 29, Issue SUPPL. 1, 2011, Pages 56-59

  Pox, Christian ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Colorectal cancer screening; Fecal occult blood testing; Genetic stool testing; M2 PK; Stool tests

Indexed keywords

GUAIAC; ISOENZYME; PYRUVATE KINASE;

CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; COLORECTAL ADENOMA; COLORECTAL CANCER; CONFERENCE PAPER; EARLY DIAGNOSIS; FECES ANALYSIS; GENETIC STOOL TEST; HUMAN; IMMUNOCHEMISTRY; M2 PYRUVATE KINASE STOOL EXAMINATION; NETHERLANDS; NON INVASIVE PROCEDURE; OCCULT BLOOD TEST; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY AND SPECIFICITY; SYMPTOM;

COLONIC NEOPLASMS; EARLY DETECTION OF CANCER; FECES; HEALTH PLANNING GUIDELINES; HUMANS;

EID: 81855173777     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000331127     Document Type: Conference Paper

References (18)

1. Mandel JS, Bond JH, Church TR, et al: Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328: 1365-1371. (Pubitemid 23131388)
2. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O: Randomised study of screening for colorectal cancer with faecal-occultblood test. Lancet 1996; 348: 1467-1471. (Pubitemid 26400241)
3. Jorgensen OD, Kronborg O, Fenger C: A randomised study of screening for colorectal cancer using faecal occult blood testing: Results after 13 years and seven biennial screening rounds. Gut 2002; 50: 29-32. (Pubitemid 34028299)
4. Scholefield JH, Moss S, Sufi F, Mangham CM, Hardcastle JD: Effect of faecal occult blood screening on mortality from colorectal cancer: Results from a randomised controlled trial. Gut 2002; 50: 840-844. (Pubitemid 34539047)
5. Lindholm E, Brevinge H, Haglind E: Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg 2008; 95: 1029-1036.
6. Faivre J, Dancourt V, Lejeune C, et al: Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 2004; 126: 1674-1680. (Pubitemid 38736331)
7. Mandel JS, Church TR, Bond JH, et al: The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343: 1603-1607. (Pubitemid 32162983)
8. Morikawa T, Kato J, Yamaji Y, et al: A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005; 129: 422-428. (Pubitemid 41096630)
9. Van Rossum LG, van Rijn AF, Laheij RJ, et al: Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008; 135: 82-90. (Pubitemid 351899018)
10. Hol L, van Leerdam ME, van Ballegooijen M, et al: Screening for colorectal cancer: Randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010; 59: 62-68.
11. Hundt S, Haug U, Brenner H: Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med 2009; 150: 162-169.
12. Van Roon AH, Wilschut JA, Hol L, et al: Diagnostic yield improves with collection of two samples in fecal immunochemical test screening without affecting attendance. Clin Gastroenterol Hepatol 2011; 9: 333-339.
13. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME: Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004; 351: 2704-2714. (Pubitemid 39665324)
14. Itzkowitz SH, Jandorf L, Brand R, et al: Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol 2007; 5: 111-117. (Pubitemid 46096834)
15. Haug U, Hundt S, Brenner H: Sensitivity and specificity of faecal tumour M2 pyruvate kinase for detection of colorectal adenomas in a large screening study. Br J Cancer 2008; 99: 133-135. (Pubitemid 351920225)
16. Levin B, Lieberman DA, McFarland B, et al: Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134: 1570-1595. (Pubitemid 351615355)
17. Sung JJ, Lau JY, Young GP, et al: Asia-Pacific consensus recommendations for colorectal cancer screening. Gut 2008; 57: 1166-1176.
18. European Commission: European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis. 2010